Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 10 of 29

COMPLETED

Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19)

NCT05175339

COMPLETED NA

Pilot Testing A Theory-Driven Self-Management Intervention for Chronic Musculoskeletal Pain

NCT05020470

COMPLETED Phase 2

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

NCT05038982

COMPLETED NA

iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis

NCT04147052

TERMINATED

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration

NCT05038371

TERMINATED Phase 1

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

NCT04749433

COMPLETED NA

Cigarette Smoking Decision Study

NCT04595279

COMPLETED NA

Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

NCT04793750

COMPLETED Phase 1

The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions

NCT04283019

COMPLETED NA

Rapid HCV Treatment Access for Persons Who Use Drugs

NCT04677153

COMPLETED NA

Art Museum Program for Seniors With Cognitive Disorders and Care-partners

NCT04696549

COMPLETED Phase 1

The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products

NCT04741477

COMPLETED

Cognitive Assessment in COVID-19 Positive Patients Using the DANA App

NCT05143333

COMPLETED

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

NCT04958889

COMPLETED NA

Aligning Medications With What Matters Most

NCT04938648

COMPLETED NA

Dietary Approaches to Stop Hypertension for Diabetes

NCT04286555

COMPLETED Phase 1

Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse

NCT04195776

COMPLETED Phase 4

Penicillin Allergy Testing in STD Clinics

NCT04620746

COMPLETED NA

Virtual Patient Education From Real Cases

NCT04553640

COMPLETED NA

Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women

NCT04829721

COMPLETED NA

Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF

NCT04809207

COMPLETED Phase 2

Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

NCT04884308

COMPLETED NA

Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation

NCT03096262

COMPLETED

Enteric Neural Precursor Cells (ENPC) in the Human Gut

NCT04880538

TERMINATED

Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment

NCT04859829

COMPLETED NA

Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders

NCT04857281

COMPLETED NA

Impact of Nursing Involvement on Implementation of HIV Prevention Services

NCT05095818

COMPLETED

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

NCT01448915

COMPLETED NA

Cuff(SZ): The Cuff Size Blood Pressure Measurement Trial

NCT04610775

COMPLETED NA

Environmental Localization Mapping and Guidance for Visual Prosthesis Users

NCT04359108

COMPLETED NA

Adapting an Evidenced-based Weight Management Intervention and Testing Strategies to Increase Implementation in Community Mental Health Programs

NCT03454997

TERMINATED Phase 4

Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye

NCT04498468

COMPLETED NA

Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity

NCT04724330

COMPLETED Early Phase 1

Intra-operative Uterosacral Ligament Bupivacaine Injection During Minimally Invasive Hysterectomy

NCT04157075

COMPLETED NA

Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics

NCT04796961

COMPLETED NA

Families Talking Together Plus: An Approach to Promote Sexual Delay and Strengthen Sexual Risk Avoidance Education

NCT04731649

COMPLETED NA

Improving Communication for Primary Care Patients

NCT04819191

COMPLETED Phase 1

Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW

NCT04760691

COMPLETED NA

A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations

NCT04696653

COMPLETED Phase 1

The Use of Eculizumab in HELLP Syndrome

NCT04103489

COMPLETED NA

Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis

NCT04054050

TERMINATED NA

Peri-Atrial Inflammatory Fat and Atrial Fibrillation

NCT04186169

COMPLETED

Pleural Manometry for the Characterization of Spontaneous and Tension Pneumothorax

NCT04630301

COMPLETED NA

Community Collaboration to Combat COVID-19 (C-FORWARD)

NCT04673292

COMPLETED NA

COVID-19 Preventive Behavior in African Americans

NCT04700462

COMPLETED Phase 3

A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain

NCT04504812

COMPLETED NA

Lidocaine Patch for Neck Pain

NCT04378959

COMPLETED NA

CGM Use in Poorly Controlled Youth With Type 1 Diabetes

NCT04721145

COMPLETED NA

Pilot Study of Video and Telephone Primary Care Visits

NCT04496713

COMPLETED NA

CGM Use in Children With Type 2 Diabetes

NCT04721158

← Previous Page 10 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.